These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 19010194

  • 1. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
    Crespo-Leiro MG, Paniagua MJ, Marzoa R, Grille Z, Naya C, Flores X, Rodriguez JA, Mosquera V, Franco R, Castro-Beiras A.
    Transplant Proc; 2008 Nov; 40(9):3060-2. PubMed ID: 19010194
    [Abstract] [Full Text] [Related]

  • 2. Ezetimibe in heart transplantation: initial experience.
    Moro J, Almenar L, Martínez-Dolz L, Izquierdo M, Agüero J, Sánchez-Lazaro I, Ortiz V, Salvador A.
    Transplant Proc; 2007 Sep; 39(7):2389-92. PubMed ID: 17889199
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.
    Aliabadi AZ, Mahr S, Dunkler D, Grömmer M, Zimpfer D, Wolner E, Grimm M, Zuckermann AO.
    Transplantation; 2008 Dec 27; 86(12):1771-6. PubMed ID: 19104420
    [Abstract] [Full Text] [Related]

  • 4. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 27; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia.
    Jones PH, Goldberg AC, Knapp HR, Kelly MT, Setze CM, Stolzenbach JC, Sleep DJ.
    Am Heart J; 2010 Oct 27; 160(4):759-66. PubMed ID: 20934572
    [Abstract] [Full Text] [Related]

  • 6. Treatment with ezetimibe in kidney transplant recipients with uncontrolled dyslipidemia.
    López V, Gutiérrez C, Gutiérrez E, Sola E, Cabello M, Burgos D, González Molina M.
    Transplant Proc; 2008 Nov 27; 40(9):2925-6. PubMed ID: 19010149
    [Abstract] [Full Text] [Related]

  • 7. Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.
    Negredo E, Moltó J, Puig J, Cinquegrana D, Bonjoch A, Pérez-Alvarez N, López-Blázquez R, Blanco A, Clotet B, Rey-Joly C.
    AIDS; 2006 Nov 14; 20(17):2159-64. PubMed ID: 17086055
    [Abstract] [Full Text] [Related]

  • 8. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.
    Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM.
    Liver Transpl; 2009 May 14; 15(5):504-8. PubMed ID: 19399742
    [Abstract] [Full Text] [Related]

  • 9. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun 14; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 10. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP.
    Curr Med Res Opin; 2007 Sep 14; 23(9):2183-92. PubMed ID: 17692154
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.
    Curr Med Res Opin; 2008 Mar 14; 24(3):685-94. PubMed ID: 18226326
    [Abstract] [Full Text] [Related]

  • 12. Safety and effects on the lipid and C-reactive protein plasma concentration of the association of ezetimibe plus atorvastatin in renal transplant patients treated by cyclosporine-A: a pilot study.
    Panichi V, Manca-Rizza G, Paoletti S, Taccola D, Consani C, Sbragia G, Mantuano E, Marchetti V, Carpi A, Barsotti G.
    Biomed Pharmacother; 2006 Jun 14; 60(5):249-52. PubMed ID: 16740374
    [Abstract] [Full Text] [Related]

  • 13. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients.
    Rodríguez-Ferrero ML, Anaya F.
    Transplant Proc; 2008 Dec 14; 40(10):3492-5. PubMed ID: 19100421
    [Abstract] [Full Text] [Related]

  • 14. Ezetimibe effectively lowers LDL-cholesterol in cardiac allograft recipients on stable statin therapy.
    Konstandin MH, Blessing E, Doesch A, Ammon K, Koch A, Wabnitz GH, Gleissner CA, Remppis A, Katus HA, Dengler TJ.
    Clin Transplant; 2008 Dec 14; 22(5):639-44. PubMed ID: 18492070
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of ezetimibe in a sample of cardiac transplant patients.
    Guisado Rasco A, Lage Gallé E, Sobrino Márquez JM, Sánchez Brotons JA, Mogollón Jiménez MV, Borrego Domínguez JM, Martínez Martínez A.
    Transplant Proc; 2008 Nov 14; 40(9):3058-9. PubMed ID: 19010193
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    Stein EA, Ballantyne CM, Windler E, Sirnes PA, Sussekov A, Yigit Z, Seper C, Gimpelewicz CR.
    Am J Cardiol; 2008 Feb 15; 101(4):490-6. PubMed ID: 18312764
    [Abstract] [Full Text] [Related]

  • 17. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec 15; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE, Bays HE, Leiter LA, Bird SR, Rubino J, Lowe RS, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2008 Dec 01; 102(11):1489-94. PubMed ID: 19026302
    [Abstract] [Full Text] [Related]

  • 19. Safety of statins when response is carefully monitored: a study of 336 heart recipients.
    Marzoa-Rivas R, Crespo-Leiro MG, Paniagua-Marin MJ, Llinares-García D, Muñiz-Garcia J, Aldama-López G, Piñón-Esteban P, Campo-Pérez R, Castro-Beiras A.
    Transplant Proc; 2005 Nov 01; 37(9):4071-3. PubMed ID: 16386629
    [Abstract] [Full Text] [Related]

  • 20. Supratherapeutic response to ezetimibe administered with cyclosporine.
    Koshman SL, Lalonde LD, Burton I, Tymchak WJ, Pearson GJ.
    Ann Pharmacother; 2005 Sep 01; 39(9):1561-5. PubMed ID: 16030077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.